Helus Pharma Inc. (HELP) company profile

Cybin Inc. is a Canadian pharmaceutical company that focuses on research and development activities within the pharmaceutical preparations sector. The organization operates through research operations and subsidiary entities, including Helus Pharma, Adelia, Journey, and Serenity. It maintains laboratory equipment, software, and intellectual property portfolios, such as patents and operating rights, to advance its scientific programs. Because the provided corporate records focus on development assets, research expenditures, and laboratory infrastructure rather than commercial sales, specific commercial customers and consumer segments are not detailed.

The enterprise conducts business and holds corporate subsidiaries across several countries, including Canada, the United States, Ireland, and the United Kingdom. Its international corporate structure includes Cybin IRL Limited and Cybin UK Ltd., alongside North American units. Cybin maintains its principal executive offices and corporate headquarters at 100 King Street West, Suite 5600, in Toronto, Ontario, Canada.

Summary of the business section of Helus Pharma's latest annual report, written by StockData.